Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations

被引:53
作者
Mallia, P.
Contoli, M.
Caramori, G.
Pandit, A.
Johnston, S. L.
Papi, A.
机构
[1] Univ Ferrara, Res Ctr Asthma & COPD, I-44100 Ferrara, Italy
[2] Royal Glamorgan Hosp, Llantrisant, Wales
[3] Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst Infect & Immun, London, England
[4] Natl Heart & Lung Inst, Dept Resp Med, London, England
基金
英国医学研究理事会;
关键词
asthma; COPD; exacerbations; viral infection; lung; airway inflammation; prevention; treatment;
D O I
10.2174/138161207779313777
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Asthma and chronic obstructive pulmonary disease (COPD) are the 2 most prevalent chronic airway diseases. Much of the morbidity, mortality and health care costs of the diseases are associated with acute exacerbations, which are episodes of increased symptoms and airflow obstruction. Over the last decade evidence has emerged implicating virus respiratory tract infections as a major cause of exacerbations of both asthma and COPD. Current therapies are not very effective in the prevention or treatment of virus-induced exacerbations and exacerbations are therefore a major unmet medical need. The development of new and novel treatments requires a better understanding of the molecular and cellular mechanisms linking virus infection with exacerbations of asthma and COPD. This article provides an overview of current knowledge regarding the mechanisms of virus-induced exacerbations in both asthma and COPD. It will also review existing treatments and future treatments that are in advanced stages of development.
引用
收藏
页码:73 / 97
页数:25
相关论文
共 245 条
[1]   Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [J].
Aaron, SD ;
Vandemheen, KL ;
Hebert, P ;
Dales, R ;
Stiell, IG ;
Ahuja, J ;
Dickinson, G ;
Brison, R ;
Rowe, BH ;
Dreyer, J ;
Yetisir, E ;
Cass, D ;
Wells, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2618-2625
[2]   Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease [J].
Aaron, SD ;
Angel, JB ;
Lunau, M ;
Wright, K ;
Fex, C ;
Le Saux, N ;
Dales, RE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (02) :349-355
[3]   Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: A re-evaluation of previously published data of a placebo-controlled randomized study [J].
Allegra, L ;
Blasi, F ;
de Bernardi, B ;
Cosentini, R ;
Tarsia, P .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (02) :149-155
[4]   HEALTH-EFFECTS OF AN AIR-POLLUTION EPISODE IN LONDON, DECEMBER 1991 [J].
ANDERSON, HR ;
LIMB, ES ;
BLAND, JM ;
DELEON, AP ;
STRACHAN, DP ;
BOWER, JS .
THORAX, 1995, 50 (11) :1188-1193
[5]   Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project [J].
Anderson, HR ;
Spix, C ;
Medina, S ;
Schouten, JP ;
Castellsague, J ;
Rossi, G ;
Zmirou, D ;
Touloumi, G ;
Wojtyniak, B ;
Ponka, A ;
Bacharova, L ;
Schwartz, J ;
Katsouyanni, K .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (05) :1064-1071
[6]  
[Anonymous], 2001, GUID DOC US IN VITR
[7]  
[Anonymous], THORAX S1
[8]  
[Anonymous], 2001, BURD LUNG DIS
[9]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[10]  
Balbi B, 1997, EUR RESPIR J, V10, P846